Adaptive Trial Designs Need Elaborate Firewalls To Prevent Data "Leakage," US FDA Says
Executive Summary
Sponsors should realize that only a very few people – think 4, not 50 – will be permitted to be unblinded, CDER's Laura Lee Johnson tells the DIA annual meeting.